Skip to main content
VCbacked
Log inGet Started

Quoin Pharmaceuticals

Ashburn, United States

Quoin Pharmaceuticals is into developing products which address major unmet medical needs.

$104.5M raised
Oct 2025
Post-IPO Equity
BiotechnologyMedicalPharmaceutical

Top Investors

Soleus CapitalADAR1 Capital ManagementNantahala Capital ManagementVelan CapitalAIGH Capital Management

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Quoin Pharmaceuticals

How much funding has Quoin Pharmaceuticals raised?
Quoin Pharmaceuticals has raised $104.5M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in October 2025.
Who are Quoin Pharmaceuticals's investors?
Quoin Pharmaceuticals's investors include Soleus Capital, ADAR1 Capital Management, Nantahala Capital Management, Velan Capital, AIGH Capital Management.
Where is Quoin Pharmaceuticals headquartered?
Quoin Pharmaceuticals is headquartered in Ashburn, United States.
What does Quoin Pharmaceuticals do?
Quoin Pharmaceuticals is into developing products which address major unmet medical needs.
What stage is Quoin Pharmaceuticals at?
Quoin Pharmaceuticals is at the Post-IPO Equity stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Quoin Pharmaceuticals — Funding & Investors." VCBacked, October 10, 2025, https://www.vcbacked.co/company/quoin-pharmaceuticals. Accessed July 2, 2026.
APA
VCBacked. (2025). Quoin Pharmaceuticals — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/quoin-pharmaceuticals
Wikipedia (cite web)
{{cite web |title=Quoin Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/quoin-pharmaceuticals |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Renaissance BioScience
Vancouver$599K
Allterum Therapeutics
Houston$1.0M
Rapport Therapeutics
Boston$250.0M
AlpalifeBio
Woburn$9.8M
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K